EA202191684A1 - Средство, содержащее урсодезоксихолевую кислоту, для лечения или профилактики пресбиопии - Google Patents

Средство, содержащее урсодезоксихолевую кислоту, для лечения или профилактики пресбиопии

Info

Publication number
EA202191684A1
EA202191684A1 EA202191684A EA202191684A EA202191684A1 EA 202191684 A1 EA202191684 A1 EA 202191684A1 EA 202191684 A EA202191684 A EA 202191684A EA 202191684 A EA202191684 A EA 202191684A EA 202191684 A1 EA202191684 A1 EA 202191684A1
Authority
EA
Eurasian Patent Office
Prior art keywords
prevention
ursodeoxycholic acid
treatment
presbiopia
drug containing
Prior art date
Application number
EA202191684A
Other languages
English (en)
Russian (ru)
Inventor
Масатомо Като
Томоко Ода
Кадзутака Кидо
Original Assignee
Сантен Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сантен Фармасьютикал Ко., Лтд. filed Critical Сантен Фармасьютикал Ко., Лтд.
Publication of EA202191684A1 publication Critical patent/EA202191684A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
EA202191684A 2018-12-18 2019-12-17 Средство, содержащее урсодезоксихолевую кислоту, для лечения или профилактики пресбиопии EA202191684A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018236717 2018-12-18
PCT/JP2019/049352 WO2020129964A1 (ja) 2018-12-18 2019-12-17 ウルソデオキシコール酸を含有する老視の治療または予防剤

Publications (1)

Publication Number Publication Date
EA202191684A1 true EA202191684A1 (ru) 2021-09-01

Family

ID=71100366

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202191684A EA202191684A1 (ru) 2018-12-18 2019-12-17 Средство, содержащее урсодезоксихолевую кислоту, для лечения или профилактики пресбиопии

Country Status (16)

Country Link
US (3) US20220072012A1 (https=)
EP (1) EP3900728A4 (https=)
JP (2) JP6771698B1 (https=)
KR (1) KR20210105916A (https=)
CN (1) CN113164499A (https=)
AU (1) AU2019407391A1 (https=)
BR (1) BR112021011653A2 (https=)
CA (1) CA3123370A1 (https=)
EA (1) EA202191684A1 (https=)
IL (1) IL284004A (https=)
MX (1) MX2021007161A (https=)
MY (1) MY203280A (https=)
PH (1) PH12021551412A1 (https=)
SG (1) SG11202106216SA (https=)
TW (1) TW202038966A (https=)
WO (1) WO2020129964A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2021007161A (es) * 2018-12-18 2021-10-13 Santen Pharmaceutical Co Ltd Agente que contiene acido ursodesoxicolico para tratar o prevenir la presbicia.
WO2022173043A1 (ja) * 2021-02-15 2022-08-18 参天製薬株式会社 ウルソデオキシコール酸またはその塩を含有する水性医薬組成物
US20220349486A1 (en) * 2021-04-29 2022-11-03 Baker Hughes Oilfield Operations Llc Modulating pilot valve adapter
TW202412751A (zh) * 2022-08-09 2024-04-01 日商參天製藥股份有限公司 含有udca或其鹽之水性醫藥組合物
CN116211804B (zh) * 2023-05-09 2025-09-05 北京汇诚益健医药科技有限责任公司 熊去氧胆酸脂质组合物及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3069612A3 (en) 2009-06-15 2016-10-19 Encore Health, LLC Dithiol compounds, derivatives, and uses therefor
CN102178784B (zh) * 2011-04-20 2013-06-12 威海康博尔生物药业有限公司 一种用于缓解视疲劳的药物组合物
WO2013025840A1 (en) * 2011-08-15 2013-02-21 Massachusetts Eye And Ear Infirmary Methods for preserving photoreceptor cell viability following retinal detachment
CN104083381A (zh) * 2014-07-29 2014-10-08 上海中医药大学 熊去氧胆酸的医药用途
WO2016029197A1 (en) * 2014-08-22 2016-02-25 Kang Zhang Compositions and methods to treat and/or prevent vision disorders of the lens of the eye
CN106074568B (zh) * 2015-09-02 2021-05-14 盛世泰科生物医药技术(苏州)有限公司 一种用于预防和治疗白内障的眼用制剂及其制备方法
WO2018147685A1 (ko) * 2017-02-09 2018-08-16 주식회사 유스바이오팜 우르소데옥시콜산을 함유하는 시각장애 예방 또는 치료용 조성물
KR102252450B1 (ko) 2017-02-09 2021-05-14 주식회사 아미코젠파마 우르소데옥시콜산을 함유하는 시각장애 예방 또는 치료용 조성물
JP6637217B2 (ja) 2017-03-06 2020-01-29 株式会社坪田ラボ 近視予防又は抑制剤、マウス近視誘導モデルの作製方法、及び、近視予防又は抑制医薬スクリーニング方法
MX2021007161A (es) 2018-12-18 2021-10-13 Santen Pharmaceutical Co Ltd Agente que contiene acido ursodesoxicolico para tratar o prevenir la presbicia.

Also Published As

Publication number Publication date
BR112021011653A2 (pt) 2021-09-08
IL284004A (en) 2021-08-31
AU2019407391A1 (en) 2021-07-01
EP3900728A4 (en) 2022-08-17
US20220072012A1 (en) 2022-03-10
EP3900728A1 (en) 2021-10-27
US20220096497A1 (en) 2022-03-31
KR20210105916A (ko) 2021-08-27
WO2020129964A1 (ja) 2020-06-25
MY203280A (en) 2024-06-21
MX2021007161A (es) 2021-10-13
CA3123370A1 (en) 2020-06-25
JP2021006548A (ja) 2021-01-21
PH12021551412A1 (en) 2022-05-02
TW202038966A (zh) 2020-11-01
SG11202106216SA (en) 2021-07-29
US20230040386A1 (en) 2023-02-09
JPWO2020129964A1 (ja) 2021-02-15
CN113164499A (zh) 2021-07-23
US11419880B2 (en) 2022-08-23
JP6771698B1 (ja) 2020-10-21

Similar Documents

Publication Publication Date Title
EA202191684A1 (ru) Средство, содержащее урсодезоксихолевую кислоту, для лечения или профилактики пресбиопии
MX378707B (es) Compuestos para el tratamiento de enfermedades y trastornos oftalmicos.
JOP20200011B1 (ar) مركبات وتركيبات لمعالجة حالات مرضية مرتبطة بنشاط nlrp
EA202090019A1 (ru) Спироциклические индолины в качестве модуляторов il-17
CO2018011064A2 (es) Inhibidores de bromodominios
PH12020550341A1 (en) Niraparib formulations
EA201590847A1 (ru) Новые ингибиторы rock
CY1125488T1 (el) Παραγωγα πυριδινης και θεραπευτικες χρησεις αυτων ως αναστολεις trpc6
EA202191683A1 (ru) Средство, содержащее 4-фенилбутират, для профилактики или лечения пресбиопии
MX2020009235A (es) Formulacion oftalmica.
EA201691058A1 (ru) Производные пирролопирролона и их применение для лечения заболеваний
MX391392B (es) ANILLOS 5-5 FUSIONADOS COMO INHIBIDORES C5a.
MX389496B (es) Compuestos de benzodiazolio como inhibidores del canal de sodio epitelial (enac)
BR112016026552A8 (pt) derivados de carboxamida, seus usos, composição farmacêutica, e combinação
EA202191548A1 (ru) Ингибиторы плазменного калликреина человека
JOP20190053A1 (ar) مركبات أزا إندازول للاستخدام في إصابات الأوتار و/ أو الرباط
MX377919B (es) Composiciones farmaceuticas solidas que comprenden derivados de biopterina y usos de tales composiciones.
JOP20190086A1 (ar) مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب
EA202190510A1 (ru) Новое лекарственное средство для лечения воспалительной болезни кишечника
MX384072B (es) Compuesto derivado de pirrolo-piridina, metodo para preparar el mismo y composicion farmaceutica que contiene el mismo como ingrediente activo para la prevencion o el tratamiento de enfermedades relacionadas con la proteina cinasa.
PH12019500618A1 (en) Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease
MX2019003365A (es) Composiciones de ester de colina de acido lipoico y metodos para estabilizar en productos farmacologicos farmaceuticamente relevantes.
EA201991817A1 (ru) Интраназальная композиция, включающая бетагистин
CL2020001426A1 (es) Composición tópica oftálmica que comprende ácido dobesilico para tratar enfermedades del segmento posterior del ojo.
EA201800565A1 (ru) Композиция для лечения заболеваний уха, содержащая (+)-азасетрон